Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.16(+0.97%)
Nasdaq
19,003.65
+31.23(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

Verrica Pharmaceuticals Inc. (VRCA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

0.9945

+0.0045

(+0.45%)

At close: 04:00PM EST

0.9700

-0.02

(-2.46%)

After hours:

07:24PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	45.35M
Enterprise Value	69.50M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	5.02
Price/Book (mrq)	238.54
Enterprise Value/Revenue	7.55
Enterprise Value/EBITDA	-11.70

Trading Information

Stock Price History

Beta (5Y Monthly)	1.46
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	11.4100
52 Week Low ³	0.7040
50-Day Moving Average ³	1.3682
200-Day Moving Average ³	5.0130

Share Statistics

Avg Vol (3 month) ³	972.29k
Avg Vol (10 day) ³	841.16k
Shares Outstanding ⁵	45.6M
Implied Shares Outstanding ⁶	N/A
Float ⁸	19.66M
% Held by Insiders ¹	16.20%
% Held by Institutions ¹	16.43%
Shares Short (Oct 31, 2024) ⁴	4.37M
Short Ratio (Oct 31, 2024) ⁴	4.35
Short % of Float (Oct 31, 2024) ⁴	19.94%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	9.59%
Shares Short (prior month Sep 30, 2024) ⁴	3.63M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	1,162.49%

Management Effectiveness

Return on Assets (ttm)	-71.41%
Return on Equity (ttm)	-2,059.89%

Income Statement

Revenue (ttm)	9.21M
Revenue Per Share (ttm)	0.20
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-73.39M
Net Income Avi to Common (ttm)	-84.99M
Diluted EPS (ttm)	-1.8400
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	22.96M
Total Cash Per Share (mrq)	0.5
Total Debt (mrq)	47.11M
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	1.34
Book Value Per Share (mrq)	-0.75

Cash Flow Statement

Operating Cash Flow (ttm)	-59.37M
Levered Free Cash Flow (ttm)	-31.81M